Summary and Implications
There are currently many unanswered questions surrounding the prevalence of perchlorate in the environment, the possible exposures and effects, and the risk management strategies available to manage perchlorate contamination. Further information must be obtained in each of these areas in order to develop successful and appropriate strategies for handing perchlorate contamination now and in the future. Because of the uncertainty involved in evaluating toxicological data, the states and federal agencies using this information may use and interpret it somewhat differently to promulgate different standards and advisory levels. It is important to note that the status of the knowledge of perchlorate exposure and risks continues to evolve and it will be essential to periodically re-evaluate what is known about this chemical. However, the reference dose recommended by National Research Council and adopted by the U.S. Environmental Protection Agency will protect the health of even the most sensitive groups of people over a lifetime of exposure.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Motzer, W.E. Perchlorate: Problems, detection, and solutions. Environ. Forensics. 2001;2:301–311.
Urbansky, E.T. Perchlorate chemistry: implications for analysis and remediation. Bioremed. J. 1998; 2:81–95.
Gibbs, J.P., Ahmad, R., Crump, K.S., Houck, D.P., Leveille, T.S., Findley, J.E., Francis, M. Evaluation of a population with occupational exposure to airborne ammonium perchlorate for possible acute or chronic effects on thyroid function. J Occup. Environ. Med. 1998; 40:1072–1082.
Braverman, L.E., He, X., Pino, S., Cross, M., Magnani, B., Lamm, S.H., Kruse, M.B., Engel, A., Crump, K.S., and Gibbs, J.P. The effect of perchlorate, thiocyanate, and nitrate on thyroid function in workers exposed to perchlorate long-term. The Journal of Clinical Endocrinology & Metabolism. 2005; 90(2):700–706.
Greenspan, F.S. The role of fine-needle aspiration biopsy in the management of palpable thyroid nodules. Am. J. Clin. Pathol. 1997; 108:S26–30.
Scanlon, M.F, Issa, B.G., Dieguez, C. Regulation of growth hormone secretion. Horm. Res. 1996;46(4–5):149–54.
Capen, C.C. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol. Pathol. 1997; 25:39–48.
Wolff, J. Perchlorate and the thyroid gland. Pharmacolog. Rev. 1998; 50:89–105.
Yu, K.O., Narayanan, L., Mattie, D.R., Godfrey, R.J., Todd, P.N., Sterner, T.R., Mahle, D.A., Lumpkin, M.H., Fisher, J.W. 2002. The pharmacokinetics of perchlorate and its effect on the hypothalamus-pituitary-thyroid axis in the male rat. Toxicol. Appl. Pharmacol. 2002; 182:148–159.
Greer, M.A., Goodman, G., Pleus, R.C., Greer, S.E. Health effects assessment for environmental perchlorate contamination: The dose response for inhibition of thyroidal radioiodine uptake in humans. Environ. Health Perspect. 2002; 110:927–937.
Merrill, E.A., Clewell, R.A., Gearhart, J.M., Robinson, P.J., Sterner, T.R., Yu, K.O., Mattie, D.R., Fisher, J.W. PBPK predictions of perchlorate distribution and its effect on thyroid uptake of radioiodide in the male rat. Toxicol. Sci. 2003; 73:256–269.
Merrill, E.A., Clewell, R.A., Robinson, P.J., Jarabek, A.M., Gearhart, J.M., Sterner, T.R., Fisher, J.W. PBPK model for radioactive iodide and perchlorate kinetics and perchlorate-induced inhibition of iodide uptake in humans. Toxicol. Sci. 2005; 83:25–43.
Clewell, R.A., Merrill, E.A., Yu, K.O., Mahle, D.A., Sterner, T.R., Mattie, D.R., Robinson, P.J., Fisher, J.W., Gearhart, J.M. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: A physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat. Toxicol. Sci. 2003a; 73:235–255.
Clewell, R.A., Merrill, E.A., Yu, K.O., Mahle, D.A., Sterner, T.R., Fisher, J.W., Gearhart, J.M. Predicting neonatal perchlorate dose and inhibition of iodide uptake in the rat during lactation using physiologically-based pharmacokinetic modeling. Toxicol. Sci. 2003b; 74:416–436.
Caldwell, D.J., King, J.H., Kinkead, E.R., Wolfe, R.E., Narayanan, L., Mattie, D.R. Results of a fourteen day oral-dosing toxicity study of ammonium perchlorate. In: 1995 JANNAF Safety and Environmental Protection Subcommittee Meeting: Volume 1, Tampa, FL. Joint Army, Navy, NASA, Air Force (JANNAF) Interagency Propulsion Committee Publication 634. Columbia, MD: Chemical Propulsion Information Agency. 1995.
Siglin, J.C, Mattie, D.R., Dodd, D.E., Hildebrandt, P.K., Baker, W.H. A 90-Day drinking water toxicity study in rats of the environmental contaminant ammonium perchlorate. Toxicol. Sci. 2000; 57:61–74.
Keil, D., Warren, D.A., Jenny, M., EuDaly, J., Dillard, R. Effects of ammonium perchlorate on immunotoxicological, hematological, and thyroid parameters in B6C3F1 female mice. Medical University of South Carolina, Charleston, SC. Final report of contract DSWA01-97-0008. 1999
Narayanan, L. Consultative letter, AFRL-HE-WP-CL-2000-0034. Thyroid hormone and TSH co-laboratory study report [memorandum with attachments to Annie Jarabek], Wright-Patterson Air Force Base, Dayton, OH: Air Force Research Laboratory. June 15, 2000.
York, R.G., Lewis, E., Brown, W.R., Girard, M.F., Mattie, D.R., Funk, K.A. and Strawson, J.S. 2005a. Refining the Effects Observed in a Developmental Neurobehavioral Study of Ammonium Perchlorate Administered Orally in Drinking Water to Rats. I-Thyroid and Reproductive Effects (In Press).
York, R.G., Barnett, Jr, J., Girard, M.F., Mattie, D.R., Bekkedal, M., Garman, R.H. and Strawson, J.S. 2005b. Refining the Effects Observed in a Developmental Neurobehavioral Study of Ammonium Perchlorate Administered Orally in Drinking Water to Rats. II — Behavioral and Neurodevelopment Effects (In Press).
U.S. Environmental Protection Agency. Disposition of Comments and Recommendations for Revisions to “Perchlorate Environmental Contamination: Toxicological Review and Risk Characterization External Review Draft (January 16, 2002).” National Center for Environmental Assessment, Washington, DC. October 27, 2003a.
York, R.G., Brown, W.R., Girard, M.F., Dollarhide, J.S. Oral (drinking water) developmental toxicity study of ammonium perchlorate in New Zealand white rabbits. Int. J. Toxicol. 2001a; 20:199–205.
York, R.G., Funk, K.A., Girard, M.F., Mattie, D., Strawson, J.E. Oral (drinking water) developmental toxicity study of ammonium perchlorate in Sprague-Dawley rats. Int. J. Toxicol. 2003; 22:453–464.
York, R.G., Barnett, J., Brown, W.R., Garman, R.H., Mattie, D.R., Dodd, D. A rat neurodevelopmental evaluation of offspring, including evaluation of adult and neonatal thyroid, from mothers treated with ammonium perchlorate in drinking water. Int. J. Toxicol. 2004; 23:191–214.
Bekkedal, M.Y.V., Carpenter, T., Smith, J., Ademujohn, C, Maken, D., Mattie, D.R. A neurodevelopmental study of the effects of oral ammonium perchlorate exposure on the motor activity of pre-weanling rat pups. Naval Health Research Center Detachment (Toxicology), Wright-Patterson AFB, OH. TOXDET-00-03. 2000.
Bekkedal, M.Y.V., Arffsten, D., Mattie, D. An evaluation of neurobehavioral tests used to assess the neurodevelopmental effects of early ammonium perchlorate exposure. J. Toxicol. Environ. Health A. 2004; 67:835–844.
York, R.G., Brown, W.R., Girard, M.F., Dollarhide, J.S. Two-generation reproduction study of ammonium perchlorate in drinking water in rats evaluates thyroid toxicity. Int. J. Toxicol. 2001b; 20:183–197.
Soldin, O.P., Braverman, L.E., Lamm, S.H. Perchlorate clinical pharmacology and human health: a review. Ther. Drug Monit. 2001; 23:316–331.
Lamm, S.H., and M. Doemland. Has perchlorate in drinking water increased the rate of congenital hypothyroidism? J. Occup. Environ. Med. 1999; 41(5):409–411.
Li, Z., F.X. Li, D. Byrd, G.M. Deyhle, D.E. Sesser, M.R. Skeels, and S.H. Lamm. Neonatal thyroxine level and perchlorate in drinking water. J. Occup. Environ. Med. 2000; 42(2):200–205.
Li, F.X., D.M. Byrd, G.M. Deyhle, D.E. Sesser, M.R. Skeels, S.R. Katkowsky, and S.H. Lamm. Neonatal Thyroid-Stimulating Hormone Level and Perchlorate in Drinking Water. Teratology. 2000; 62(6):429–431.
Li, F.X., L. Squartsoff, and S.H. Lamm. Prevalence of thyroid diseases in Nevada counties with respect to perchlorate in drinking water. J. Occup. Environ. Med. 2001; 43(7):630–634.
Chang, S., C. Crothers, S. Lai, and S. Lamm. Pediatric neurobehavioral diseases in Nevada counties with respect to perchlorate in drinking water: An ecological inquiry. Birth Defects Res. Part A Clin. Mol. Teratol. 2003; 67(10):886–892.
Brechner, R.J., Parkhurst, G.D., Humble, W.O., Brown, M.B., Herman, W.H. Ammonium perchlorate contamination of Colorado River drinking water is associated with abnormal thyroid function in newborns in Arizona. J. Occup. Environ. Med. 2000; 42:777–782.
Schwartz, J. Gestational Exposure to Perchlorate is Associated with Measures of Decreased Thyroid Function in a Population of California Neonates. M.S. Thesis, University of California, Berkeley. 2001.
Kelsh, M.A., P.A. Buffler, J.J. Daaboul, G.W. Rutherford, E.C. Lau, J.C. Cahill, A.K. Exuzides, A.K. Madl, L.G. Palmer, and F.W. Lorey. Primary congenital hypothyroidism, newborn thyroid function, and environmental perchlorate exposure among residents of a southern California community. J. Occup. Environ. Med. 2003; 45(10): 1116–1127.
Lamm, S. H. Perchlorate exposure does not explain differences in neonatal thyroid function between Yuma and Flagstaff. [Letter]. J. Occup. Environ. Med. 2003; 45(11): 1131–1132.
Buffler, P.A., M.A. Kelsh, E.C. Lau, C.H. Edinboro, and J.C. Barnard. 2004. Epidemiologic Studies of Primary Congenital Hypothyroidism and Newborn Thyroid Function Among California Residents, Final Report. April 2004, Berkeley, CA.
Morgan, J.W., and R.E. Cassady. 2002. Community cancer assessment in response to long-time exposure to perchlorate and trichloroethylene in drinking water. J. Occup. Environ. Med. 44(7):616–621.
Brabant, G., Bergmann, P., Kirsch, CM., Kohrle, J., Hesch, R.D., von zur Muhlen, A. Early adaptation of thyrotropin and thyroglobulin secretion to experimentally decreased iodine supply in man. Metabolism. 1992; 41:1093–1096.
Braverman, L.E., X. He, S. Pino, B. Magnani, and A. Firek. The effect of low dose perchlorate on thyroid function in normal volunteers [abstract]. Thyroid. 2004; 14(9):691.
Lawrence, J.E., Lamm, S.H., Pino, S., Richman, K., Braverman, L.E. The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid. 2000; 10:659–663.
Lawrence, J., Lamm, S., Braverman, L.E. Low dose perchlorate (3 mg daily) and thyroid function. Thyroid 2001; 11:295.
Lamm, S.H., Braverman, L.E., Li, F.X., Richman, K., Pino, S., Howearth, G. Thyroid health status of ammonium perchlorate workers: A cross-sectional occupational health study. J. Occup. Environ. Med. 1999; 41:248–260.
Crump, C, Michaud, P., Tellez, R., Reyes, C, Gonzalez, G., Montgomery, E.L., Crump, K.S., Lobo, G., Becerra, C, Gibbs, J.P. Does perchlorate in drinking water affect thyroid function in newborns or school-age children? J. Occup. Environ. Med. 2000; 42:603–612.
Tellez, R.T., Chacon, P.M., Abarca, C.R., Blount, B.C., Van Landingham, C.B., Crump, K.S., and Gibbs, J.P. Chronic Environmental Exposure to Perchlorate Through Drinking Water and Thyroid Function During Pregnancy and the Neonatal Period. Thyroid. 2005; (In Press).
Hill, R.N., Erdreich, L.S., Paynter, O.E., Roberts, P.A., Rosenthal, S.L., Wilkinson, C.F. Thyroid follicular cell carcinogenesis. Fundam. Appl. Toxicol. 1989; 12:629–697.
National Research Council. 2005a. Health Implications of Perchlorate Ingestion. Washington, D.C.: National Academies Press.
Barnes, D.G., Dourson, M.L. Reference dose (RfD): Description and use in health risk assessments. Reg. Toxicol. Pharmacol. 1988; 8:471–486.
Dourson, M.L. Methods for establishing oral reference doses. In: Risk Assessment of Essential Elements. W. Mertz, C. O. Abernathy, and S. S. Olin, eds. Washington, D.C.: ILSI Press. Ch. 51–61. 1994.
U.S. Environmental Protection Agency. A Review of the Reference Dose and Reference Concentration Processes. Risk Assessment Forum. Washington, DC. May 2002. EPA/630/P-02/002A.
U.S. Environmental Protection Agency. Integrated Risk Information System (IRIS). Glossary of Terms. Office of Research and Development. Washington, DC. 2003b. Available online: http://www.USEPA.gov/iris.
Haber, L.T., Dollarhide, J.S., Maier, A., Dourson, M.L. Noncancer Risk Assessment: Principles and Practice in Environmental and Occupational Settings. In Patty’s Toxicology. E. Bingham, B. Cohrssen and C.H. Powell Ed. 5th ed, Wiley and Sons, Inc. New York, NY. p. 169–232. 2001.
University of Nebraska. Perchlorate State of the Science Symposium. University of Nebraska Medical Center, Omaha, Nebraska. September 29th to October 1, 2003. Available online: http://www.unmc.edu/coned.
Strawson, J., Zhao, Q., Dourson, M. Reference dose for perchlorate based on thyroid hormone change in pregnant women as the critical effect. Regul. Toxicol. Pharmacol. 2004;39(1):44–65.
Capen, C.C. Toxic responses of the endocrine system. In: Casarett and Doull’s Toxicology The Basic Science of Poisons. 6th edition. C. D. Klaassen, ed. New York: McGraw-Hill. Ch. 21. pp.724. 2001.
Toxicology Excellence for Risk Assessment (TERA). Use of human data in risk assessment. Comments submitted to U.S. EPA. February 19, 2002.
Meek, M., Renwick, A., Ohanian, E., Dourson, M., Lake, B., Naumann, B., Vu, V. Guidelines for application of compound specific adjustment factors (CSAF) in dose/concentration response assessment. Comm. Toxicol. 2001; 7:575–590.
Mattie, D.R., Sterner, T.R., Merrill, E.A., Clewell, R.A., Zhao, Q., Strawson, J.E., Dourson, M.L. Use of Human and Animal PBPK Models in Risk Assessment for Perchlorate. The Toxicoiogist. 2004; 78(S-1): 361.
BRT. Ammonium perchlorate: Effect on immune function. Quality assurance audit: study no. BRT 19990524 — plaque forming cell (PFC) assay; study no. BRT 19990525 — local lymph node assay (LLNA) in mice. Burleson Research Technologies, Inc., Raleigh, NC. Study # BRT 19990524 & 19990525. 2000.
Kessler, F.J., Krüskemper, H.J. (1966). Experimented Schilddrüsentumoren durch mehrjährige Zufuhr von Kaliumperchlorat [Experimental thyroid tumors caused by long-term potassium perchlorate administration]. Klin. Wochenschr. 1966; 44:1154–1156.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Mattie, D.R., Strawson, J., Zhao, J. (2006). Perchlorate Toxicity and Risk Assessment. In: Gu, B., Coates, J.D. (eds) Perchlorate. Springer, Boston, MA. https://doi.org/10.1007/0-387-31113-0_8
Download citation
DOI: https://doi.org/10.1007/0-387-31113-0_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-31114-2
Online ISBN: 978-0-387-31113-5
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)